Jundishapur Journal of Microbiology

Published by: Kowsar

Frequency Assessment of OXA-10 and PER β-Lactamase Genes and Determination of Minimum Inhibitory Concentration in Klebsiella Strains Isolated from Urinary Tract Infections

Farshad Kakian 1 , Milad Shahini Shams Abadi 1 , Behnam Zamanzad 2 , Hasan Najafi 2 , Masoud Amiri 3 and Abolfazl Gholipour 2 , *
Authors Information
1 Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2 Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Social Health Determinants Research Center and Epidemiology and Biostatistics, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
Article information
  • Jundishapur Journal of Microbiology: 12 (2); e65500
  • Published Online: February 17, 2019
  • Article Type: Research Article
  • Received: December 24, 2017
  • Revised: January 9, 2019
  • Accepted: January 16, 2019
  • DOI: 10.5812/jjm.65500

To Cite: Kakian F, Shahini Shams Abadi M, Zamanzad B, Najafi H, Amiri M, et al. Frequency Assessment of OXA-10 and PER β-Lactamase Genes and Determination of Minimum Inhibitory Concentration in Klebsiella Strains Isolated from Urinary Tract Infections, Jundishapur J Microbiol. Online ahead of Print ; 12(2):e65500. doi: 10.5812/jjm.65500.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135(1):41-50. [PubMed: 11434731].
  • 2. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008;(1). CD001321. doi: 10.1002/14651858.CD001321.pub4. [PubMed: 18253990].
  • 3. Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, et al. Underlying mechanisms of carbapenem resistance in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: Role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents. 2013;41(1):75-9. doi: 10.1016/j.ijantimicag.2012.08.010. [PubMed: 23142087].
  • 4. Chaudhary B, Insan NG, Payal N. ESBL and AmpC detection in Klebsiella species by non molecular methods. Int J Curr Microbiol App Sci. 2014;3(4):323-9.
  • 5. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589-603. [PubMed: 9767057]. [PubMed Central: PMC88898].
  • 6. Oteo J, Cercenado E, Fernandez-Romero S, Saez D, Padilla B, Zamora E, et al. Extended-spectrum-beta-lactamase-producing Escherichia coli as a cause of pediatric infections: Report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain. Antimicrob Agents Chemother. 2012;56(1):54-8. doi: 10.1128/AAC.05103-11. [PubMed: 21986825]. [PubMed Central: PMC3256038].
  • 7. Timofte D, Dan M, Maciuca IE, Ciucu L, Dabija ER, Guguianu E, et al. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit. Eur J Clin Microbiol Infect Dis. 2015;34(10):2069-74. doi: 10.1007/s10096-015-2453-3. [PubMed: 26239064].
  • 8. Korzeniewska E, Harnisz M. Beta-lactamase-producing Enterobacteriaceae in hospital effluents. J Environ Manage. 2013;123:1-7. doi: 10.1016/j.jenvman.2013.03.024. [PubMed: 23563146].
  • 9. Shah AA, Hasan F, Ahmed S, Hameed A. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol. 2004;155(6):409-21. doi: 10.1016/j.resmic.2004.02.009. [PubMed: 15249058].
  • 10. Farshadzadeh Z, Khosravi AD, Alavi SM, Parhizgari N, Hoveizavi H. Spread of extended-spectrum beta-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2014;40(8):1575-80. doi: 10.1016/j.burns.2014.02.008. [PubMed: 24767142].
  • 11. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2010;36(1):70-4. doi: 10.1016/j.burns.2009.01.015. [PubMed: 19524369].
  • 12. Khan SA, Feroz F, Noor R. Study of extended-spectrum β-lactamase-producing bacteria from urinary tract infections in Bangladesh. Tzu Chi Med J. 2013;25(1):39-42. doi: 10.1016/j.tcmj.2013.01.008.
  • 13. Willems E, Verhaegen J, Magerman K, Nys S, Cartuyvels R. Towards a phenotypic screening strategy for emerging beta-lactamases in Gram-negative bacilli. Int J Antimicrob Agents. 2013;41(2):99-109. doi: 10.1016/j.ijantimicag.2012.07.006. [PubMed: 23280443].
  • 14. Shahini Shams-Abadi M, Halaji M, Hoseini-Alfatemi SM, Gholipour A, Mojtahedi A, Sedigh Ebrahim-Saraie H. Epidemiology of toxic shock syndrome toxin-1 harboring Staphylococcus aureus obtained from clinical samples in Iran: A systematic review and meta-analysis. Ann Ig. 2018;30(5):391-400. doi: 10.7416/ai.2018.2239. [PubMed: 30062367].
  • 15. Shahini Shams Abadi M, Siadat SD, Vaziri F, Davari M, Fateh A, Pourazar S, et al. Distribution and diversity of hmw1A among invasive nontypeable haemophilus influenzae isolates in Iran. Avicenna J Med Biotechnol. 2016;8(2):99-102. [PubMed: 27141269]. [PubMed Central: PMC4842248].
  • 16. Gastmeier P. Nosocomial urinary tract infections: Many unresolved questions. Clin Microbiol Infect. 2001;7(10):521-2. [PubMed: 11683791].
  • 17. Nasehi L, Shahcheraghi F, Nikbin VS, Nematzadeh S. PER, CTX-M, TEM and SHV beta-lactamases in clinical isolates of Klebsiella pneumoniae isolated from Tehran, Iran. Iran J Basic Med Sci. 2010;13(3):111-8.
  • 18. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008;52(8):2818-24. doi: 10.1128/AAC.00171-08. [PubMed: 18505851]. [PubMed Central: PMC2493136].
  • 19. Damavandi MS, Gholipour A, Latif Pour M. Prevalence of class D carbapenemases among extended-spectrum beta-lactamases producing Escherichia coli isolates from educational hospitals in Shahrekord. J Clin Diagn Res. 2016;10(5):DC01-5. doi: 10.7860/JCDR/2016/17722.7739. [PubMed: 27462579]. [PubMed Central: PMC4948386].
  • 20. Saeidi S, Ghamgosha M, Taheri RA, Shiri Y, Solouki M, Hassanpour K, et al. Phenotypic and genotypic detection of extended-spectrum β-lactamase (ESBL) producing Escherichia coli isolated from urinary tract infections in Zabol, Iran. J Coastal Life Med. 2014;2(9):732-7. doi: 10.12980/jclm.2.2014jclm-2014-0063.
  • 21. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill. 2008;13(47). [PubMed: 19021957].
  • 22. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333-41. doi: 10.1086/429323. [PubMed: 15825037].
  • 23. Eftekhar F, Rastegar M, Golalipoor M, Mansoursamaei N. Detection of extended spectrum B-lactamases in urinary isolates of Klebsiella pneumoniae in relation to Bla, Bla and Bla gene carriage. Iran J Public Health. 2012;41(3):127-32. [PubMed: 23113157]. [PubMed Central: PMC3481709].
  • 24. Gholipour A, Soleimani N, Shokri D, Mobasherizadeh S, Kardi M, Baradaran A. Phenotypic and molecular characterization of extended-spectrum beta-lactamase produced by Escherichia coli, and Klebsiella pneumoniae isolates in an educational hospital. Jundishapur J Microbiol. 2014;7(10). e11758. doi: 10.5812/jjm.11758. [PubMed: 25632322]. [PubMed Central: PMC4295312].
  • 25. Jalalpoor S, Mobasherizadeh S. Frequency of ESBLs in Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized and out-patients with urinary tract infection in selective centers in Esfahan (2009-2010). Razi J Med Sci. 2011;18(85).
  • 26. Sirot DL, Goldstein FW, Soussy CJ, Courtieu AL, Husson MO, Lemozy J, et al. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: A 3-year survey in France. Antimicrob Agents Chemother. 1992;36(8):1677-81. [PubMed: 1416850]. [PubMed Central: PMC192029].
  • 27. Nathisuwan S, Burgess DS, Lewis J2. Extended-spectrum beta-lactamases: Epidemiology, detection, and treatment. Pharmacotherapy. 2001;21(8):920-8. [PubMed: 11718498].
  • 28. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit. 2006;12(11):BR362-5. [PubMed: 17072265].
  • 29. Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, et al. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries. 2010;4(10):609-15. [PubMed: 21045352].
  • 30. Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 1997;11(4):875-87. [PubMed: 9421705].
  • 31. Shanthi M, Sekar U. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. J Assoc Physicians India. 2010;58 Suppl:41-4. [PubMed: 21568008].
  • 32. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol. 2003;52(Pt 5):421-5. doi: 10.1099/jmm.0.04966-0. [PubMed: 12721319].
  • 33. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother. 2000;45(6):895-8. [PubMed: 10837447].
  • 34. Jabalameli F, Mirsalehian A, Sotoudeh N, Jabalameli L, Aligholi M, Khoramian B, et al. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Burns. 2011;37(7):1202-7. doi: 10.1016/j.burns.2011.05.012. [PubMed: 21703769].
  • 35. Luo Y, Yang J, Zhang Y, Ye L, Wang L, Guo L. Prevalence of beta-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. Int J Antimicrob Agents. 2011;37(4):352-5. doi: 10.1016/j.ijantimicag.2010.12.018. [PubMed: 21376540].
  • 36. Shacheraghi F, Shakibaie MR, Noveiri H. Molecular identification of ESBL Genes blaGES-blaVEB-blaCTX-M blaOXA-blaOXA-4, blaOXA-10 andblaPER-in Pseudomonas aeruginosa strains isolated from burn patients by PCR, RFLP and sequencing techniques. Int J Biol life Sci. 2010;3(6):138-42.
  • 37. Fallah F, Noori M, Hashemi A, Goudarzi H, Karimi A, Erfanimanesh S, et al. Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica (Cairo). 2014;2014:245162. doi: 10.1155/2014/245162. [PubMed: 25133013]. [PubMed Central: PMC4123593].
  • 38. Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the calgary health region: Importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis. 2005;192(9):1606-12. doi: 10.1086/444469. [PubMed: 16206075].
  • 39. Lagatolla C, Tonin EA, Monti-Bragadin C, Dolzani L, Gombac F, Bearzi C, et al. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital. Emerg Infect Dis. 2004;10(3):535-8. doi: 10.3201/eid1003.020799. [PubMed: 15109432]. [PubMed Central: PMC3322785].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments